Projects are reviewed and selected for funding by a panel of experts. The 2024 (Round 15) panel:
- Dr John Skidmore (Chair), Chief Scientific Officer, ALBORADA Drug Discovery Institute
- Dr Rachel Atfield, Associate Director (Life Sciences), Cambridge Enterprise
- Dr Sarah Bolton, Business Manager, Centre for Healthcare Equipment and Technology Adoption (CHEATA), Nottingham University Hospitals NHS Trust
- Prof Steve Charnock-Jones, Department of Obstetrics and Gynaecology, University of Cambridge
- Dr Nadine Clemo, Global Program Leader, Apollo Therapeutics
- Dr Dominique-Laurent Couturier, MRC Biostatistics Unit, University of Cambridge
- Dr Maria Groves, Senior Director, AstraZeneca
- Mr Stuart Kay, Director, Cambridge Medtech Solutions Ltd
- Prof David Jayne, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust
- Dr Rajesh Jena, Department of Oncology, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust
- Dr Andy Merritt, Head of Academic Engagement, LifeArc
- Dr John Pritchard, Industry Expert in Residence at the University of Cambridge
- Dr Trevor Perrior, Industry Expert in Residence at the University of Cambridge
- Dr Ben Uttenthal, Department of Haematology, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust
- Dr Nicola Wallis, Industry Expert in Residence at the University of Cambridge
- Mr David Warwick, Director, eg technology
- Ms Khadija Whiteley, Joint Head of Clinical Engineering Innovation, Cambridge University Hospitals NHS Foundation Trust
- Prof Anne Willis OBE, MRC Toxicology Unit, University of Cambridge